RxDoctor Payments Data

Kelsey Crampton

Adult Health · Lexington, MINPI 1427675768

Payments from drug & device makers

$413in general payments, 2019–2025

Across 26 payments — averaging $15.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$110
  • Novo Nordisk$79
  • Exact Sciences$53
  • Bayer$36
  • AbbVie$34
  • GSK$32
  • plus $70 from 4 others

What the payments were for

  • Food & beverage$413100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$413 in reported general payments places this provider in the 55th percentile of 527 adult health providers in Michigan.

See all adult health providers in Michigan

Medicare billing

Part B allowed, 2024
$58,828
Medicare patients
128
Services billed
847

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban70$77,613
OzempicSemaglutide30$51,542
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$38,689
XareltoRivaroxaban19$23,042
JanuviaSitagliptin Phosphate28$17,081
MounjaroTirzepatide12$16,584
JardianceEmpagliflozin19$15,603
Spiriva RespimatTiotropium Bromide15$12,026
FarxigaDapagliflozin Propanediol15$11,183
Lantus SolostarInsulin Glargine,hum.Rec.Anlog61$7,818
Breo ElliptaFluticasone/Vilanterol15$5,599
Humalog Kwikpen U-100Insulin Lispro12$3,330
Novolog FlexpenInsulin Aspart14$2,212
Levothyroxine Sodium156$2,016
Atorvastatin Calcium174$1,993

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$79$51,54230 claims
GSKTrelegy Ellipta, Breo Ellipta$32$44,28855 claims
Boehringer IngelheimJardiance, Spiriva Respimat$18$27,63034 claims
Lilly USA, LLCMounjaro$110$16,58412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 527 adult health providers in Michigan.

Other adult health in Lexington

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →